These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15358116)

  • 1. The secretable form of trimeric TRAIL, a potent inducer of apoptosis.
    Kim MH; Billiar TR; Seol DW
    Biochem Biophys Res Commun; 2004 Sep; 321(4):930-5. PubMed ID: 15358116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
    Wu X; He Y; Falo LD; Hui KM; Huang L
    Mol Ther; 2001 Mar; 3(3):368-74. PubMed ID: 11273779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine 230 modulates tumor necrosis factor-related apoptosis-inducing ligand activity.
    Seol DW; Billiar TR
    Cancer Res; 2000 Jun; 60(12):3152-4. PubMed ID: 10866303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.
    Hu B; Zhu H; Qiu S; Su Y; Ling W; Xiao W; Qi Y
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1153-62. PubMed ID: 15555548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
    Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
    Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
    J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of TRAIL(114-281) mediated by adeno-associated virus and its tumoricidal activity].
    Ma H; Liu YX; Liu SL; Xu RA; Zheng DX
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1635-41. PubMed ID: 15569460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
    Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K
    Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H; Liu Y; Liu S; Xu R; Zheng D
    Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
    Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
    J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of Trial in mammalian cell and its apoptosis activation in culture cells].
    Yao YC; Wang XM; Hu YP
    Yi Chuan Xue Bao; 2001 May; 28(5):482-6. PubMed ID: 11441662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
    Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.
    Di Pietro R; Zauli G
    J Cell Physiol; 2004 Dec; 201(3):331-40. PubMed ID: 15389537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of apoptosis-induced ligand gene in relation to tumor necrosis factor on human colon cancer cell line HT29].
    He C; Hu X; Xu X; Fang B
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):133-6. PubMed ID: 12015033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of tumour necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL): cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine.
    Trabzuni D; Famulski KS; Ahmad M
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):505-10. PubMed ID: 10947965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and biological activities of TRAIL fusion protein gene].
    Li J; Zheng Y; Chen H; Du L; Shu CL; Cheng Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):535-7. PubMed ID: 15182642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.